Table_3.xls (5.5 kB)
Cardiac and antithrombotic medication at discharge.
dataset
posted on 2015-06-01, 03:59 authored by Heli M. Lahtela, Tuomas O. Kiviniemi, Marja K. Puurunen, Axel Schlitt, Andrea Rubboli, Antti Ylitalo, José Valencia, Gregory Y. H. Lip, K. E. Juhani AiraksinenP-value < 0.05 = *, p value < 0.01 = **, all values are compared with eGFR ≥90mL/min group. Data are reported as number and percentage or mean ± SD; eGFR estimated glomerular filtration rate; VKA, vitamin K antagonist; INR, international normalized ratio; ACEi, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers
Cardiac and antithrombotic medication at discharge.
History
Usage metrics
Categories
Keywords
Renal ImpairmentAFCAS Trial BackgroundRenal impairmentfiltration rateEuropean multicenter registrycerebrovascular eventspciCox regression modelegfrAtrial Fibrillation Undergoing Coronary Intervention12 months.ResultsAhrmacce781 AF patientsciprognostic effectrisk factorAtrial fibrillationfunction.ConclusionsRenal impairmentantithrombotic medications
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC